NaviMed Pharma acquires all shares of Conflux, stock price rises 10%

[Bitu] According to market data, Hong Kong-listed company Vanguard Pharmaceutical Biotechnology (HK0399) rose over 10% during the session, with a volume currently reported at 8 million HKD.

Leading Pharmaceutical Biotechnology previously announced plans to acquire all equity of the blockchain project Conflux to expand its layout in the blockchain field. Two founding members of Conflux currently serve as its executive directors.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 10
  • Share
Comment
0/400
SatoshiLegendvip
· 20h ago
Another rhythm of playing people for suckers by riding the chain's popularity, it's just land grabbing.
View OriginalReply0
not_your_keysvip
· 20h ago
Those who trade cryptocurrencies are now playing with medical stocks.
View OriginalReply0
ProbablyNothingvip
· 07-16 03:30
What kind of medicine is the cryptocurrency trading company playing with?
View OriginalReply0
fren.ethvip
· 07-15 18:55
cfx is also going to be bought the dip.
View OriginalReply0
ZkSnarkervip
· 07-15 02:59
intuitively speaking... pharma x blockchain is peak 2024 energy
Reply0
AirdropChaservip
· 07-15 02:58
Puh, the pharmaceutical industry has become web3.
View OriginalReply0
MercilessHalalvip
· 07-15 02:48
Lock-up Position and Market Stabilization have both arrived, yet it still can't rise?
View OriginalReply0
QuorumVotervip
· 07-15 02:48
The cfx card face is good!
View OriginalReply0
SigmaBrainvip
· 07-15 02:45
Biological giants are getting into the blockchain, stay tuned!
View OriginalReply0
ProxyCollectorvip
· 07-15 02:35
Another one riding the Blockchain concept...
View OriginalReply0
View More
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)